美股市场个股详情
RCKT Rocket Pharmaceuticals
- 16.820
- -0.160-0.94%
收盘价 11/04 16:00 (美东)
- 16.820
- 0.0000.00%
盘后 16:37 (美东)
15.30亿总市值-6072市盈率TTM
17.110最高价16.428最低价71.33万股成交量16.650今开16.980昨收1202.36万成交额1.01%换手率亏损市盈率(静)9097.59万总股本32.52552周最高3.98市净率11.92亿流通值15.97552周最低--股息TTM7088.95万流通股67.480历史最高--股息率TTM4.02%振幅7.565历史最低16.856平均价1股每手
关于Rocket Pharmaceuticals公司
Rocket Pharmaceuticals Inc 是一家后期生物制药公司。公司专注于开发罕见和毁灭性儿科疾病的基因疗法。公司的渠道产品包括用于Danaon病的RP-A501、用于范可尼贫血的RP-L102、用于白细胞粘附的RP-L201、用于丙酮酸激酶缺乏症的RP-L301和用于婴儿恶性骨质疏松症的RP-L401。
公司介绍
公司代码RCKT
公司名称Rocket Pharmaceuticals
上市日期2015/02/18
发行价格6.00
成立日期1999
CEODr. Gaurav Shah, M.D.
所属市场纳斯达克
员工数量268
年结日12-31
公司地址9 Cedarbrook Drive
城市Cranbury
省份新泽西
国家美国
邮编08512
电话1-609-659-8001
董事高管
- 姓名
- 职务
- 年薪
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 801.36万
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 484.61万
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 315.78万
- Aaron Ondrey
- Chief Financial Officer
- --
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 437.77万
- Mark White
- General Manager, Commercial Affairs
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 152.76万
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 41.00万
- Dr. Mikael Dolsten, M.D.
- Director
- --
- Dr. Naveen Yalamanchi, M.D.
- Independent Director
- 41.75万
- David P. Southwell
- Independent Director
- 40.00万
- Carsten Boess
- Independent Director
- 42.75万
- Dr. Gotham Makker, M.D.
- Independent Director
- 40.00万
- Pedro P. Granadillo
- Independent Director
- 43.00万
- Robert Keith Woods
- Independent Director
- 56.87万
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 41.00万
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 40.00万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据